APA (7th ed.) Citation

Ang, Y. L. E., Ho, G. F., Soo, R. A., Sundar, R., Tan, S. H., Yong, W. P., . . . Lee, S. (2020). A randomized phase II trial evaluating the addition of low dose, short course sunitinib to docetaxel in advanced solid tumours. BMC cancer, 20(1), 1118-10. https://doi.org/10.1186/s12885-020-07616-4

Chicago Style (17th ed.) Citation

Ang, Yvonne L. E., et al. "A Randomized Phase II Trial Evaluating the Addition of Low Dose, Short Course Sunitinib to Docetaxel in Advanced Solid Tumours." BMC Cancer 20, no. 1 (2020): 1118-10. https://doi.org/10.1186/s12885-020-07616-4.

MLA (9th ed.) Citation

Ang, Yvonne L. E., et al. "A Randomized Phase II Trial Evaluating the Addition of Low Dose, Short Course Sunitinib to Docetaxel in Advanced Solid Tumours." BMC Cancer, vol. 20, no. 1, 2020, pp. 1118-10, https://doi.org/10.1186/s12885-020-07616-4.